Pharmaceuticals / services Hotline:

Company News

Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved

Release time:2021-12-12
2-1

Our new formulation L-Ornithine-L-Aspartate Infusion for injection( 5gm/10ml  ) has been approved by China SFDA on 23th April 2020. The injection registration certificate No. is H20203173.          

Reprint statement: reprint please indicate "source: Wista pharma".

Back
Luliconazole and posaconazole are launched into market

Recommend